Table 1.

Performance measure adherence.

Measures*	Type of Measure	#of Eligible Patients	Percent Meeting Measure
Diabetes
ACE or ARB if proteinuric	Process	5,097	94.8%
Statin if indicated	Process	6,356	88.4%
Annual LDL	Process	7,628	85.7%
Semi-annual PCP evaluation	Process	7,628	84.9%
Semi-annual hemoglobin A1c	Process	7,628	82.6%
Annual foot examination	Process	7,628	70.6%
Pneumococcal vaccine	Process	7,628	68.9%
Influenza vaccine	Process	7,628	63.5%
Monitor for nephropathy	Process	2,393	61.8%
Annual eye examination	Process	7,628	60.8%
Antiplatelet agent if indicated	Process	6,807	59.6%
Hemoglobin A1c ≤ 7%	Intermediate Outcome	4,033	45.5%
Hemoglobin A1c ≤ 9%	Intermediate Outcome	3,195	92.2%
Blood pressure ≤ 135/80	Intermediate Outcome	7,628	63.9%
Congestive Heart Failure
Ejection fraction (EF) assessed	Process	1,037	98.5%
Annual creatinine and potassium if on ACE or ARB	Process	717	93.0%
Statin if indicated	Process	823	87.5%
ACE or ARB if EF< 40%	Process	316	85.8%
Beta-blocker if EF< 40%	Process	336	83.6%
Annual LDL	Process	1,037	80.1%
Pneumococcal vaccine	Process	1,037	78.7%
Influenza vaccine	Process	1,037	70.8%
Blood pressure ≤ 140/90	Intermediate Outcome	1,037	81.4%
Ischemic Vascular Disease
Statin if indicated	Process	2,452	96.6%
Antiplatelet agent	Process	2,651	90.2%
Annual LDL	Process	2,672	87.4%
Beta-blocker if indicated	Process	2,611	73.3%
Pneumococcal vaccine	Process	2,672	71.4%
Influenza vaccine	Process	2,672	67.6%
Blood pressure ≤ 135/80	Intermediate Outcome	2,672	67.5%
Prevention
Pneumococcal vaccine	Process	7,729	77.8%
Breast cancer screening	Process	14,983	75.9%
Cervical cancer screening	Process	34,992	75.8%
Influenza vaccine	Process	14,622	59.9%

^*See Table, Supplemental Digital Content 1, for a more detailed description of the measure criteria.